HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR Gives Wheat Proteins Tentative “Safe” Review Despite Uncertainties

This article was originally published in The Rose Sheet

Executive Summary

The CIR Expert Panel issued a tentative final safety assessment for hydrolyzed wheat protein and hydrolyzed wheat gluten at its September meeting, along with a list of stipulations in order for the ingredients to be used safely.

You may also be interested in...



CIR: New Research On Controversial Ingredients Should Be Considered

The Cosmetic Ingredient Review Expert Panel will take a look at new research on cosmetic ingredients as needed, even if an ingredient in question is not up for review.

Final CIR Assessment: Formaldehyde Unsafe In Heated Hair-Smoothers

The Cosmetic Ingredient Review Expert Panel issued a final safety assessment for formaldehyde/methylene glycol at its Sept. 26-27 meeting – declaring the ingredient unsafe for use in heated hair-smoothing products – after grappling with questions concerning its role and the information it should consider when evaluating cosmetic substances.

Women’s Voices For The Earth Will Keep After CIR, Salon Worker Safety In 2024

Women’s Voices for the Earth continues to call attention to cosmetic ingredients’ potential health impacts on users including salon workers, while pushing the Cosmetic Ingredient Review to consider a wider variety of safety information in its assessment work.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018718

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel